Table 1 Characteristics of the 26 children with septic shock included in the study
From: Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
|  | Septic shock (n = 26) |
|---|---|
Age (years) | 2.12 [0.47–4.60] |
Male gender [n (%)] | 11 (42) |
Complex chronic conditions [n (%)] | 9 (35) |
Primary nosocomial infection | 1 (3.9) |
Site of initial infection [n (%)] | |
 Blood | 3 (11.5) |
 Lung | 4 (15.4) |
 Abdomen | 8 (30.8) |
 Multi-site | 9 (34.6) |
 Others | 1 (3.9) |
 No documentation | 1 (3.9) |
Microbiology | |
 Gram-negative bacteria | |
  Neisseria meningitidis | 8 (30.8) |
  Escherichia coli | 3 (11.5) |
  Klebsiella species | 2 (7.7) |
  Enterobacter species | 2 (7.7) |
  Campylobacter jejuni | 1 (3.8) |
  Haemophilus influenzae | 1 (3.8) |
 Gram-positive bacteria | |
  Streptococcus pneumoniae | 3 (11.5) |
  Streptococcus pyogenes | 2 (7.7) |
  Staphylococcus aureus | 1 (3.8) |
 Viruses | |
  Parainfluenzae virus | 1 (3.8) |
PIM2 admission (%) | 8.1 [3.2–17.4] |
PELOD-2 | |
 Day 1 | 9.5 [2.75–12.0] |
 Day 3 | 4.0 [0.0–10.0] |
 Day 7 | 0.0 [0.0–5.0] |
CVI | 4.0 [0.0–7.0] |
ICU-free days in 30 days | 23.0 [19.0–26.0] |
Secondary acquired infections [n (%)] | 8 (30) |
Mortality [n (%)] | 2 (7) |